As the US imposes punitive tariffs on over $60 billion of Indian exports, investors are left grappling with the implications for their portfolios. In...
Across Europe, frustration over soaring executive pay and government austerity has been boiling over into strikes, protests, and even shareholder revolts. By September 2025,...
Intellia Therapeutics (NASDAQ: NTLA) has been getting a lot of buzz lately among investors who follow the biotech space. The company uses CRISPR gene...
Across Europe, frustration over soaring executive pay and government austerity has been boiling over into strikes, protests, and even shareholder revolts. By September 2025,...